- Reagents In The Kit
-
LNK163STR: 3 Vials of 10ug LYNX lyophilized Streptavidin mix
1 Vial LYNX Modifier reagent
1 Vial LYNX Quencher reagent.
-
LNK162STR: 1 Vial of 1mg LYNX lyophilized Streptavidin mix
1 Vial LYNX Modifier reagent
1 Vial LYNX Quencher reagent.
-
LNK161STR: 3 Vials of 100μg LYNX lyophilized Streptavidin mix
1 Vial LYNX Modifier reagent
1 Vial LYNX Quencher reagent.
- Preparing The Antibody
-
LNK163STR
The following buffer solutions are recommended for preparing the antibody:
10-50mM amine-free buffer (e.g HEPES, MES, MOPS and phosphate) pH range 6.5-8.5, although moderate concentrations of Tris buffer (<20mM) may be tolerated.
Do not use buffers containing nucleophilic components e.g primary amines and thiols since they may react with LYNX chemicals. Azide (0.02-0.1%), EDTA and common non-buffering salts and sugars have little or no effect on conjugation efficiency.
It is recommended that 10μg antibody be used in each labelling reaction. For optimal results the antibody should be at a concentration of 1mg/ml, with a maximum volume of 10μl and a maximum antibody amount of 10μg. Antibody at a concentration of greater than 1mg/ml requires dilution. Antibody below 1mg/ml can still be used as long as the maximum volume is not exceeded. Using less than the recommended amount of antibody may result in unbound label, but this will be removed during subsequent application wash steps. Antibody below 0.5mg/ml should be concentrated before use with the kit.
-
LNK162STR
The following buffer solutions are recommended for preparing the antibody:
10-50mM amine-free buffer (e.g HEPES, MES, MOPS and phosphate) pH range 6.5-8.5, although moderate concentrations of Tris buffer (<20mM) may be tolerated.
Do not use buffers containing nucleophilic components e.g primary amines and thiols since they may react with LYNX chemicals. Azide (0.02-0.1%), EDTA and common non-buffering salts and sugars have little or no effect on conjugation efficiency.
It is recommended that 1mg antibody be used in each labelling reaction. For optimal results the antibody should be at a concentration of 1mg/ml, with a maximum volume of 1ml and a maximum antibody amount of 1mg. Antibody at a concentration of greater than 1mg/ml requires dilution. Antibody below 1mg/ml can still be used as long as the maximum volume is not exceeded. Using less than the recommended amount of antibody may result in unbound label, but this will be removed during subsequent application wash steps. Antibody below 0.5mg/ml should be concentrated before use with the kit.
-
LNK161STR
The following buffer solutions are recommended for preparing the antibody:
10-50mM amine-free buffer (e.g HEPES, MES, MOPS and phosphate) pH range 6.5-8.5, although moderate concentrations of Tris buffer (<20mM) may be tolerated.
Do not use buffers containing nucleophilic components e.g primary amines and thiols since they may react with LYNX chemicals. Azide (0.02-0.1%), EDTA and common non-buffering salts and sugars have little or no effect on conjugation efficiency.
It is recommended that 100μg antibody be used in each labelling reaction. For optimal results the antibody should be at a concentration of 1mg/ml, with a maximum volume of 100μl and a maximum antibody amount of 100μg. Antibody at a concentration of greater than 1mg/ml requires dilution. Antibody below 1mg/ml can still be used as long as the maximum volume is not exceeded. Using less than the recommended amount of antibody may result in unbound label, but this will be removed during subsequent application wash steps. Antibody below 0.5mg/ml should be concentrated before use with the kit.
- Regulatory
- For research purposes only.
- Guarantee
- 12 months from date of despatch.
- Licensed Use
-
LNK163STR, LNK161STR
Bio-Rad LYNX conjugation kits are offered for research purposes alone, and are not intended for human, therapeutic or diagnostic use. The purchase of this conjugation kit conveys to the buyer (whether the buyer is a
not-for-profit, academic or for-profit entity) the non-transferable
right to use the amount of product purchased and
the components of the product for in-house research. The
buyer shall not sell or otherwise transfer this product, its
components, or materials prepared therefrom to any third
party. The buyer shall not use this product or its components
for commercial purposes. For the avoidance of doubt,
‘commercial purposes’ means any activity by a party for
consideration and includes, without limitation, use of the
product or its components (I) in the manufacturing of
conjugated materials (e.g. labeled antibodies), (ii) to provide
a service, information or data, (iii) for therapeutic, diagnostic
or prophylactic purposes, or (iv) for repackaging/resale,
whether or not such product or its components are resold for
use in research. The use of this product by the buyer
constitutes agreement with the terms of this limited use label
license for LYNX products.
-
LNK162STR
Bio-Rad LYNX conjugation kits are offered for research purposes alone, and are not intended for human, therapeutic or diagnostic use. The purchase of this conjugation kit conveys to the buyer (whether the buyer is a
not-for-profit, academic or for-profit entity) the non-transferable
right to use the amount of product purchased and
the components of the product for in-house research. The
buyer shall not sell or otherwise transfer this product, its
components, or materials prepared therefrom to any third
party. The buyer shall not use this product or its components
for commercial purposes. For the avoidance of doubt,
?commercial purposes? means any activity by a party for
consideration and includes, without limitation, use of the
product or its components (I) in the manufacturing of
conjugated materials (e.g. labeled antibodies), (ii) to provide
a service, information or data, (iii) for therapeutic, diagnostic
or prophylactic purposes, or (iv) for repackaging/resale,
whether or not such product or its components are resold for
use in research. The use of this product by the buyer
constitutes agreement with the terms of this limited use label
license for LYNX products.